Physician

Daniel M Berinstein, M.D.

According to 2025 Medicare claims, Daniel Berinstein, M.D. (NPI: 1366416406) practices ophthalmology in the Frederick-Gaithersburg-Bethesda, MD market, with the plurality of this provider's patient population coming from Montgomery, MD. This provider's primary affiliated billing organization is THE RETINA GROUP OF WASHINGTON, PLLC (NPI: 1225001654; TIN: 521570295) and primary practice location at 20815-6956. Berinstein is affiliated with the Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Berinstein's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,785 traditional Medicare patients, billed 38,254 HCPCS/CPT codes, and received $4,837,033 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 366 prescription claims across 114 beneficiaries totaling $38,468 in drug costs, led by Lumigan (Bimatoprost). Open Payments data shows 5 records totaling $162. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $1,943,253 to $4,837,033. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.